SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
830.00    14.00 (1.72%)
Bid:
824.00
Ask:
828.00
Spread: 4.00 (0.485%)
Market Cap: £382.60m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Board Change

26 Jun 2023 07:00

RNS Number : 7885D
Porvair PLC
26 June 2023
Β 

For immediate release 26 June 2023

Β 

Β 

Porvair plc

("Porvair" or the "Group" or the "Company")

Β 

Board change

Β 

Porvair is pleased to announce the appointment of Sarah Vawda as an independent Non-Executive Director of the Company with effect from 26 June 2023.

Sarah is the Senior Independent Non-Executive Director and Chair of the Audit Committee of Access Intelligence plc, an AIM listed reputation management, marketing and communications, software as a service business; Non-Executive Director of Hamlet Protein A/S, a private equity backed Danish specialty protein business; and Non-Executive Director and Chair of the Remuneration and Nomination Committees of Noveltech Private Feeds Ltd (India), a private equity backed Indian animal nutrition business. She was formerly Non-Executive Director and Chair of the Audit and Risk Committees at Burger King UK; Trustee and Chair of the Audit Committee at The Girls Network; and Governor of the University of Bedfordshire.

Sarah has previously held senior executive roles within Global multinational companies including Powergen Plc, Corus Group plc, Christian Salvesen plc, Provimi SA and Johnson Matthey plc. She qualified as a chartered accountant with PwC.

On appointment, Sarah will join the Audit Committee, Remuneration Committee and Nominations Committee of Porvair plc.

Porvair confirms that there are no further matters in relation to Sarah Vawda's appointment to be disclosed pursuant to the requirements of paragraph 9.6.13 of the Listing Rules of the UK Listing Authority.

Β 

For further information, please contact:

Β 

Porvair plc

01553 765 500

Ben Stocks, Chief Executive

Chris Tyler, Group Company Secretary

Buchanan Communications

0207 466 5000

Charles Ryland / Simon Compton / Jack Devoy

Β 

Notes to Editors

Porvair is a group of specialist filtration, laboratory and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. It operates in three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAFLFIERAIVFIV
Date   Source Headline
22nd May 20269:16 amRNSHolding(s) in Company
22nd May 20269:15 amRNSHolding(s) in Company
28th Apr 20267:00 amRNSAppointment of Joint Corporate Broker
24th Apr 20264:30 pmRNSHolding(s) in Company
24th Apr 202610:15 amRNSHolding(s) in Company
14th Apr 20264:29 pmRNSResults of AGM
14th Apr 20267:00 amRNSAGM Trading Update
1st Apr 20264:30 pmRNSTotal Voting Rights
26th Mar 20262:00 pmRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSNotice of AGM
11th Mar 20267:00 amRNSNotice of AGM
3rd Mar 202610:00 amRNSHolding(s) in Company
27th Feb 20263:00 pmRNSTotal Voting Rights
24th Feb 20265:45 pmRNSDirector/PDMR Shareholding
19th Feb 20261:00 pmRNSHolding(s) in Company
17th Feb 20262:00 pmRNSDirector/PDMR Shareholding
13th Feb 20264:15 pmRNSDirector/PDMR Shareholding
9th Feb 20263:45 pmRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNSFull Year Results
6th Feb 20264:00 pmRNSHolding(s) in Company
3rd Feb 20262:30 pmRNSHolding(s) in Company
30th Jan 202612:00 pmRNSTotal Voting Rights
26th Jan 202610:00 amRNSHolding(s) in Company
12th Jan 20267:00 amRNSAcquisition of Drache Umwelttechnik GmbH
6th Jan 20267:00 amRNSBlock listing Return
17th Dec 202510:00 amRNSHolding(s) in Company
15th Dec 20257:00 amRNSYear end trading update and notice of results
11th Dec 20254:00 pmRNSHolding(s) in Company
5th Dec 20259:30 amRNSHolding(s) in Company
2nd Dec 202511:00 amRNSHolding(s) in Company
27th Oct 20257:00 amRNSTotal Voting Rights
7th Oct 20257:00 amRNSBlock Listing Return
25th Sep 20257:00 amRNSBoard Changes
16th Sep 20257:00 amRNSNine Month Trading Update
4th Sep 20257:30 amRNSHolding(s) in Company
23rd Jul 20255:30 pmRNSHolding(s) in Company
23rd Jul 20259:00 amRNSHolding(s) in Company
30th Jun 20257:00 amRNSInterim Results
19th Jun 202510:04 amRNSBlocklisting Application
17th Jun 20254:40 pmRNSHolding(s) in Company
29th May 202512:00 pmRNSHolding(s) in Company
28th Apr 20259:00 amRNSHolding(s) in Company
25th Apr 20259:00 amRNSHolding(s) in Company
17th Apr 20257:00 amRNSChange of Remuneration Committee Chair
15th Apr 20253:00 pmRNSHolding(s) in Company
15th Apr 20252:43 pmRNSAGM resolutions
15th Apr 20257:00 amRNSAGM Trading Update
9th Apr 202512:00 pmRNSBlock listing Interim Review
7th Apr 20258:00 amRNSDirector Declaration
4th Apr 202510:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.